Moors & Cabot’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Buy
9,525
+600
+7% +$92.5K 0.06% 285
2025
Q4
$1.38M Buy
8,925
+7
+0.1% +$1.05K 0.06% 283
2025
Q3
$1.24M Sell
8,918
-403
-4% -$54.5K 0.05% 307
2025
Q2
$1.26M Sell
9,321
-815
-8% -$110K 0.06% 283
2025
Q1
$1.48M Buy
10,136
+1,854
+22% +$269K 0.08% 245
2024
Q4
$1.14M Buy
8,282
+247
+3% +$36.1K 0.05% 308
2024
Q3
$1.24M Sell
8,035
-610
-7% -$92.5K 0.06% 280
2024
Q2
$1.26M Buy
8,645
+479
+6% +$68.7K 0.07% 255
2024
Q1
$1.21M Buy
8,166
+432
+6% +$62K 0.07% 267
2023
Q4
$1.05M Buy
7,734
+1,230
+19% +$160K 0.07% 271
2023
Q3
$837K Buy
6,504
+112
+2% +$14.9K 0.06% 299
2023
Q2
$848K Sell
6,392
-1
-0% -$132 0.06% 304
2023
Q1
$828K Sell
6,393
-758
-11% -$99K 0.06% 306
2022
Q4
$971K Buy
7,151
+76
+1% +$10.1K 0.07% 271
2022
Q3
$857K Sell
7,075
-560
-7% -$72.1K 0.07% 287
2022
Q2
$979K Buy
7,635
+48
+0.6% +$6.29K 0.07% 274
2022
Q1
$1.04M Sell
7,587
-67
-0.9% -$8.87K 0.06% 282
2021
Q4
$1.08M Buy
7,654
+190
+3% +$25.2K 0.07% 270
2021
Q3
$951K Buy
7,464
+364
+5% +$48.1K 0.06% 292
2021
Q2
$894K Sell
7,100
-643
-8% -$78.8K 0.06% 280
2021
Q1
$903K Buy
7,743
+436
+6% +$50.3K 0.07% 261
2020
Q4
$826K Sell
7,307
-716
-9% -$78.2K 0.07% 258
2020
Q3
$847K Sell
8,023
-78
-1% -$8.21K 0.08% 236
2020
Q2
$811K Buy
8,101
+216
+3% +$21.3K 0.09% 222
2020
Q1
$699K Sell
7,885
-113
-1% -$11K 0.1% 195
2019
Q4
$814K Buy
7,998
+345
+5% +$33.2K 0.08% 238
2019
Q3
$690K Buy
7,653
+2,584
+51% +$236K 0.08% 257
2019
Q2
$470K Sell
5,069
-133
-3% -$12K 0.06% 311
2019
Q1
$477K Buy
5,202
+80
+2% +$7.21K 0.06% 285
2018
Q4
$443K Sell
5,122
-1,168
-19% -$106K 0.07% 278
2018
Q3
$598K Buy
6,290
+576
+10% +$52K 0.07% 273
2018
Q2
$478K Sell
5,714
-196
-3% -$16.2K 0.06% 316
2018
Q1
$481K Buy
5,910
+439
+8% +$37.4K 0.06% 335
2017
Q4
$453K Sell
5,471
-165
-3% -$13.6K 0.06% 334
2017
Q3
$460K Buy
5,636
+1,386
+33% +$111K 0.07% 321
2017
Q2
$337K Sell
4,250
-229
-5% -$17.4K 0.06% 369
2017
Q1
$334K Buy
+4,479
New +$326K 0.06% 360
2016
Q3
Sell
-8,058
Closed -$578K 559
2016
Q2
$578K Sell
8,058
-1,929
-19% -$136K 0.1% 240
2016
Q1
$677K Sell
9,987
-966
-9% -$64.7K 0.12% 209
2015
Q4
$787K Buy
10,953
+1,986
+22% +$140K 0.14% 177
2015
Q3
$594K Buy
8,967
+1,319
+17% +$96.4K 0.11% 234
2015
Q2
$566K Buy
7,648
+250
+3% +$18.5K 0.09% 263
2015
Q1
$537K Buy
7,398
+642
+10% +$45.8K 0.09% 257
2014
Q4
$461K Buy
6,756
+1,537
+29% +$103K 0.08% 279
2014
Q3
$333K Buy
+5,219
New +$327K 0.06% 352

Other funds holding XLV

Moors & Cabot's XLV Position: Q1 2026 in Review

Moors & Cabot increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 6.7% in Q1 2026, buying an estimated $92.5K and bringing the position to 9,525 shares worth $1.4M. The position accounts for 0.06% of the portfolio, ranked #285.

Moors & Cabot first reported a position in XLV in Q3 2014 and has held it in 45 quarters since. The position peaked at $1.48M in Q1 2025. 1,807 funds tracked by Wall St. Rank hold XLV as of Q1 2026.

  • Moors & Cabot held 9,525 shares of State Street Health Care Select Sector SPDR ETF worth $1.4M as of Q1 2026.
  • Moors & Cabot bought 600 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $92.5K.
  • State Street Health Care Select Sector SPDR ETF made up 0.06% of Moors & Cabot's portfolio in Q1 2026, its #285 holding.
  • Moors & Cabot first reported a position in State Street Health Care Select Sector SPDR ETF in Q3 2014 and has held it in 45 quarters since.
  • Moors & Cabot's State Street Health Care Select Sector SPDR ETF position peaked at $1.48M in Q1 2025.
  • 1,807 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.